Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinet...

por MacGowan, Alasdair P., Bowker, Karen E.
Publicado em 2003

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia

por Mpenge, Mbiye A, MacGowan, Alasdair P
Publicado no Ther Clin Risk Manag (2015)

Early warning score: a dynamic marker of severity and prognosis in patients with Gram-negative bacteraemia and sepsis

por Albur, Mahableshwar, Hamilton, Fergus, MacGowan, Alasdair P.
Publicado no Ann Clin Microbiol Antimicrob (2016)

Comparative Bactericidal Activities of Daptomycin and Vancomycin against Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA Isolates

por Wootton, Mandy, MacGowan, Alasdair P., Walsh, Timothy R.
Publicado em 2006

Pharmacodynamics of Moxifloxacin against Anaerobes Studied in an In Vitro Pharmacokinetic Model

por Noel, Alan R., Bowker, Karen E., MacGowan, Alasdair P.
Publicado em 2005

Pharmacodynamics of the Antibacterial Effect and Emergence of Resistance to Tomopenem, Formerly RO4908463/CS-023, in an In Vitro Pharmacokinetic Model of Staphylococcus aureus Infe...

por MacGowan, Alasdair P., Bowker, Karen E., Noel, Alan R.
Publicado em 2008

Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model

por Bowker, Karen E., Noel, Alan R., MacGowan, Alasdair P.
Publicado em 2008

In Vitro Activities of Three New Dihydrofolate Reductase Inhibitors against Clinical Isolates of Gram-Positive Bacteria

por Bowker, Karen E., Caspers, Patrick, Gaucher, Bérengère, MacGowan, Alasdair P.
Publicado em 2009

Activity of Moxifloxacin, Administered Once a Day, against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model of Infection

por MacGowan, Alasdair P., Bowker, Karen E., Wootton, Mandy, Holt, H. Alan
Publicado em 1999

A Multicenter Study Evaluating the Current Strategies for Isolating Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides

por Wootton, Mandy, MacGowan, Alasdair P., Walsh, Timothy R., Howe, Robin A.
Publicado em 2007

Bacterial Strain-to-Strain Variation in Pharmacodynamic Index Magnitude, a Hitherto Unconsidered Factor in Establishing Antibiotic Clinical Breakpoints

por MacGowan, Alasdair P., Reynolds, Rosy, Noel, Alan R., Bowker, Karen E.
Publicado em 2009

Pharmacodynamics of Razupenem (PZ601) Studied in an In Vitro Pharmacokinetic Model of Infection

por MacGowan, Alasdair P., Noel, Alan, Tomaselli, Sharon, Elliott, Heather, Bowker, Karen
Publicado em 2011

Pharmacodynamics of Ceftaroline against Staphylococcus aureus Studied in an In Vitro Pharmacokinetic Model of Infection

por MacGowan, Alasdair P., Noel, Alan R., Tomaselli, Sharon, Bowker, Karen E.
Publicado em 2013

Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic Model

por MacGowan, Alasdair P., Rogers, Chris A., Holt, H. Alan, Bowker, Karen E.
Publicado em 2003

Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model

por MacGowan, Alasdair P., Noel, Alan R., Rogers, Chris A., Bowker, Karen E.
Publicado em 2004

Interactions between Methicillin and Vancomycin in Methicillin-Resistant Staphylococcus aureus Strains Displaying Different Phenotypes of Vancomycin Susceptibility

por Howe, Robin A., Wootton, Mandy, Bennett, Peter M., MacGowan, Alasdair P., Walsh, Timothy R.
Publicado em 1999

Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

por MacGowan, Alasdair P., Rogers, Chris A., Holt, H. Alan, Wootton, Mandy, Bowker, Karen E.
Publicado em 2001

Pharmacodynamics of Telavancin Studied in an In Vitro Pharmacokinetic Model of Infection

por MacGowan, Alasdair P., Noel, Alan R., Tomaselli, Sharon, Elliott, Heather C., Bowker, Karen E.
Publicado em 2011

Pharmacodynamics of the Antibacterial Effect of and Emergence of Resistance to Doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an In Vitro Pharmacokinetic Model

por Bowker, Karen E., Noel, Alan R., Tomaselli, Sharon G., Elliott, Heather, MacGowan, Alasdair P.
Publicado em 2012

Pharmacodynamics of Ceftolozane plus Tazobactam Studied in an In Vitro Pharmacokinetic Model of Infection

por MacGowan, Alasdair P., Noel, Alan R., Tomaselli, Sharon G., Nicholls, Donna, Bowker, Karen E.
Publicado no Antimicrob Agents Chemother (2015)